logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: disease
Load new posts () and activity
Like Reblog Comment
text 2022-08-11 14:45
7 Myths About Thyroid Disease That Should Be Addressed ASAP

The thyroid gland is a butterfly-shaped gland in your neck that produces two vital hormones (triiodothyronine and thyroxine) that regulate your body temperature, metabolism, and digestion. It also controls essential organs including your heart, brain, liver, kidneys, and skin.

 

According to the American Thyroid Association, over 60% of people with thyroid disease are unaware of their condition. Furthermore, there are various myths surrounding thyroid disease, which adds to the uncertainty and delays in diagnosis and treatment. So, in order to raise awareness of thyroid illness, we've debunked some of the most popular misconceptions about it.

 

1. Thyroid disease has clear symptoms

People often believe that if you have thyroid issues, you can quickly tell if something is wrong with your thyroid gland since the symptoms are so obvious. Truth be told, thyroid illness signs might occasionally be imperceptible and simple to miss.

 

Unfortunately, thyroid illness can be very difficult to detect since the symptoms are vague or overlap. Particularly in women, thyroid diseases are frequently misunderstood. This is due to the potential difficulty in diagnosing thyroid issues, since their symptoms may resemble those of other female-specific illnesses including premenstrual dysphoric disorder, perimenopause, or menopause.

 

2. Thyroid disease patients will always need to take medications

It depends on what caused your illness. Thyroid issues can occur in certain women before, during, or after pregnancy. The thyroid may self-regulate once the body's hormone levels have stabilized. It's also accurate to say that prescriptions can vary over time. For instance, pregnant women with underactive thyroids may require extra thyroid hormone supplementation.

 

3.  A thyroid lump or nodule indicates malignancy

Only around 5% of thyroid nodules are cancerous on average, with the majority of nodules being benign. Your endocrinologist may encourage you to have a thyroid nodule ultrasound performed, and if further testing is necessary, a nodule needle test may be suggested.

 

4. Weight loss is impossible with hypothyroidism

Your thyroid regulates your metabolism, which determines how many calories you burn during the day. The pace at which your body can turn food into energy is slowed down by hypothyroidism, which is an underactive thyroid. Even when the thyroid is wrong, most people still need to manage all the other issues that cause weight gain.

 

It is probable that when one is using medicine to treat hypothyroidism, the basal metabolic rate decreases, making it more challenging to lose weight in comparison to someone who doesn't have hypothyroidism. That is not an excuse, though, not to live a healthy lifestyle.

 

5. Diet can help you control thyroid disease

Thyroid issues cannot be controlled only by diet. Restoring hormone production to a normal level is possible with thyroid medication. Your general health still depends on eating a balanced diet that is rich in vitamins and minerals.

 

6. Thyroid issues are just a middle-aged woman's concern

Thyroid disease may really affect both men and women of any age. However, since they have greater estrogen levels than males, women are more likely to develop any thyroid disorder, including hypothyroidism, hyperthyroidism, nodules, and thyroid cancer.

 

7. Iodine can be used to treat thyroid disease at home

It is true that your thyroid depends on iodine, which is often present in table salt, to function, therefore maintaining a healthy level of the mineral is essential. Additionally, thyroid cancer and hyperactive thyroid diseases are occasionally treated with radioactive iodine treatment (RAI). 

 

However, the majority of people really obtain enough iodine from their regular meals. In fact, consuming too much iodine may exacerbate thyroid issues by causing the body to overproduce thyroid hormone in an effort to handle the excess iodine. So avoid doing it yourself and taking iodine pills without first talking to your doctor.

Like Reblog Comment
text 2022-01-21 09:41
Infectious Disease Diagnostics Market : Rising Technological Advancements In Infectious Disease Diagnostics

Market growth is driven by the global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements.

[263 Pages Report] The global infectious disease diagnostics market size is projected to reach USD 39.8 billion by 2026 from USD 28.1 billion in 2021, at a CAGR of 7.2%.

This study involved four major activities in estimating the current size of the infectious disease diagnostics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Market Dynamics

  • Global prevalence of infectious diseases and onset of COVID-19
  • Rising focus on R&D and funding in infectious disease diagnostics
  • Growing awareness for early disease diagnosis in developing countries
  • Rising technological advancements in infectious disease diagnostics
  • Shift in focus from centralized laboratories to decentralized POC testing

COVID-19 Impact on Global Infectious Disease Diagnostics Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (CHINA) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies but had an positive impact on the infectious disease diagnostics market because of the use of infectious disease diagnostic methods for COVID-19 testing. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589

Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.

The infectious disease diagnostics market is segmented into immunodiagnostics, polymerase chain reaction (PCR), clinical microbiology, isothermal nucleic acid amplification technology (INAAT), DNA sequencing & NGS, DNA microarrays, and other technologies. In 2020, the immunodiagnostics segment accounted for the largest share. This can be attributed to the increasing use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East & Africa

The global infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global infectious disease diagnostics market. The North American infectious disease diagnostics market’s growth can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.

Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

Some key players mentioned in the research report are:

  • Abbott Laboratories (US)
  • Roche Diagnostics Ltd. (Switzerland)
  • bioMérieux SA (France)
  • Thermo Fisher Scientific Inc. (US)
  • Danaher Corporation (US)

    Market growth is driven by the global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements.

    [263 Pages Report] The global infectious disease diagnostics market size is projected to reach USD 39.8 billion by 2026 from USD 28.1 billion in 2021, at a CAGR of 7.2%.

    This study involved four major activities in estimating the current size of the infectious disease diagnostics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

    Market Dynamics

    • Global prevalence of infectious diseases and onset of COVID-19
    • Rising focus on R&D and funding in infectious disease diagnostics
    • Growing awareness for early disease diagnosis in developing countries
    • Rising technological advancements in infectious disease diagnostics
    • Shift in focus from centralized laboratories to decentralized POC testing

    COVID-19 Impact on Global Infectious Disease Diagnostics Market

    COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (CHINA) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies but had an positive impact on the infectious disease diagnostics market because of the use of infectious disease diagnostic methods for COVID-19 testing. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents.

    Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589

    Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.

    The infectious disease diagnostics market is segmented into immunodiagnostics, polymerase chain reaction (PCR), clinical microbiology, isothermal nucleic acid amplification technology (INAAT), DNA sequencing & NGS, DNA microarrays, and other technologies. In 2020, the immunodiagnostics segment accounted for the largest share. This can be attributed to the increasing use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation.

    The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East & Africa

    The global infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global infectious disease diagnostics market. The North American infectious disease diagnostics market’s growth can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.

    Request for sample pages @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

    Some key players mentioned in the research report are:

    • Abbott Laboratories (US)
    • Roche Diagnostics Ltd. (Switzerland)
    • bioMérieux SA (France)
    • Thermo Fisher Scientific Inc. (US)
    • Danaher Corporation (US)
Like Reblog Comment
text 2021-09-30 09:01
Infectious Disease Diagnostics MarketĀ : Rising Technological Advancements In Infectious Disease Diagnostics

Market growth is driven by the global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements.

[263 Pages Report] The global infectious disease diagnostics market size is projected to reach USD 39.8 billion by 2026 from USD 28.1 billion in 2021, at a CAGR of 7.2%.

This study involved four major activities in estimating the current size of the infectious disease diagnostics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Market Dynamics

  • Global prevalence of infectious diseases and onset of COVID-19
  • Rising focus on R&D and funding in infectious disease diagnostics
  • Growing awareness for early disease diagnosis in developing countries
  • Rising technological advancements in infectious disease diagnostics
  • Shift in focus from centralized laboratories to decentralized POC testing

COVID-19 Impact on Global Infectious Disease Diagnostics Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (CHINA) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies but had an positive impact on the infectious disease diagnostics market because of the use of infectious disease diagnostic methods for COVID-19 testing. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589

Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.

The infectious disease diagnostics market is segmented into immunodiagnostics, polymerase chain reaction (PCR), clinical microbiology, isothermal nucleic acid amplification technology (INAAT), DNA sequencing & NGS, DNA microarrays, and other technologies. In 2020, the immunodiagnostics segment accounted for the largest share. This can be attributed to the increasing use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation.

The geographical regions mapped in the report are:1. North America2. Europe3. Asia-Pacific4. Latin America5. Middle East & Africa

The global infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global infectious disease diagnostics market. The North American infectious disease diagnostics market’s growth can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.

Request for sample pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

Some key players mentioned in the research report are:

  • Abbott Laboratories (US)
  • Roche Diagnostics Ltd. (Switzerland)
  • bioMérieux SA (France)
  • Thermo Fisher Scientific Inc. (US)
  • Danaher Corporation (US)
Source: www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html
More posts
Your Dashboard view:
Need help?